Out of the Blue

GenomicsOne's TrueBlue Cloning Scheme For the past two decades, cloners have relied on lacZ*-based color selection vectors to identify cloned inserts. These systems are based on the insertional inactivation of the lacZ* gene fragment and are (deceptively) simple. The lacZ gene encodes the ß-galactosidase (ßGal) protein, which acts on an indicator substrate to produce blue colonies. Thus, in a cloning experiment, white colonies indicate that the DNA of interest has been inserted into t

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


GenomicsOne's TrueBlue Cloning Scheme
For the past two decades, cloners have relied on lacZ*-based color selection vectors to identify cloned inserts. These systems are based on the insertional inactivation of the lacZ* gene fragment and are (deceptively) simple. The lacZ gene encodes the ß-galactosidase (ßGal) protein, which acts on an indicator substrate to produce blue colonies. Thus, in a cloning experiment, white colonies indicate that the DNA of interest has been inserted into the lacZ* coding region of the vector, disrupting ßGal expression, while blue colonies indicate that lacZ is intact and insertion has not occurred. However, many blue-white screeners find that this color selection method can be quite inaccurate, and one study found that approximately 30-40 percent of blue colonies actually contained inserts.1 GenomicsOne Corp. of Montreal has come to the rescue with its TrueBlue Technology, which provides a highly reliable blue-white selection procedure.

False negatives can occur when ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies